View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.
Shashank Upadhye is a partner at Amin Talati Upadhye, LLP. For 20+ years, he has focused on pharmaceutical law, with an emphasis on IP and FDA issues. He also spent many years as the chief of legal/IP/FDA counsel at Apotex, Sandoz, and Eon Labs, so he brings key business savvy to client help. He is a prolific speaker and recognized leader in the Hatch Waxman/Para. IV field. He counsels both brand companies [505(b)(2) applicants] seeking to strategically patent and launch their brand name products in the long term; and to generic companies seeking to challenge patents (opinions and litigation), maximize 180-day exclusivity, and with FDA compliance (483’s, Warning Letters, and enforcement). He provides input at every stage of the product lifecycle from product selection, R&D, regulatory affairs, product launch, and ongoing marketing/sales. Shashank is also the author of the key legal text on pharmaceutical and FDA law. He can be reached at: [email protected] and his bio is here: http://amintalati.com/professionals/shashank-upadhye/